MedDataX Logo

The Intra-Aortic Balloon Pumps Insertion Registry on Behalf of the Groupe Des Angioplasticiens de la Région Ouest

NCT ID: NCT02900456

Last Updated: 2017-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

177 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Interventional Cardiology

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intra-aortic Balloon Pumps Registry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females at least of 18 of age;
* Undergoing IABP treatment ;
* Subject, relatives or legal guardian signified their non-opposition to participate in the study

Exclusion Criteria

\- IABP insertion in immediate post-intervention period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume LEURENT

Role: PRINCIPAL_INVESTIGATOR

CHU Rennes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Angers

Angers, , France

Site Status

Clinique Saint Joseph

Angers, , France

Site Status

CHU Brest

Brest, , France

Site Status

CHU Caen

Caen, , France

Site Status

Hôpital Prive Saint Martin

Caen, , France

Site Status

CH Chartres

Chartres, , France

Site Status

CH Laval

Laval, , France

Site Status

CH Le Mans

Le Mans, , France

Site Status

CH Bretagne Sud

Lorient, , France

Site Status

CHU Nantes

Nantes, , France

Site Status

Nouvelles Cliniques Nantaises

Nantes, , France

Site Status

CH Intercommunal de Cornouaille

Quimper, , France

Site Status

CHU Rennes

Rennes, , France

Site Status

Hôpital privé Beauregard

Rennes, , France

Site Status

Polyclinique Saint-Laurent

Rennes, , France

Site Status

CHU Rouen

Rouen, , France

Site Status

Clinique Saint-Hilaire

Rouen, , France

Site Status

CH Saint-Brieuc

Saint-Brieuc, , France

Site Status

CH Saint-Nazaire

Saint-Nazaire, , France

Site Status

Groupement Coopération Sanitaire Pui Cite Sanitaire

Saint-Nazaire, , France

Site Status

Communauté Hospitalière de Territoire Rance Emeraude

St-Malo, , France

Site Status

Polyclinique Les Fleurs

Toulon, , France

Site Status

CHU Tours

Tours, , France

Site Status

Clinique Saint Gatien

Tours, , France

Site Status

CH Bretagne Atlantique

Vannes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC14_8942

Identifier Type: -

Identifier Source: org_study_id